A 2126 New York Assembly · 2025 Regular Session

Relates to requiring a referenced rate for prescription drugs

This bill creates a pilot program requiring New York state health programs to pay no more than the lowest price for certain prescription drugs in Canada. It sets maximum prices based on the most recent drug pricing lists from Ontario, Quebec, British Columbia, and Alberta, starting with the five most expensive drugs. State agencies and health plans must pay these Canadian-based rates for covered drugs, and any savings generated must be passed directly to consumers through reduced costs. The program applies only to state-funded health plans and agencies purchasing drugs for state programs, excluding Medicaid.
Bill status in committee 1 of 4 stages cleared
Introduction
Jan 2025
Committee Review
Floor Vote
Governor
Introduced Jan 15, 2025 Last action Jan 27, 2026
Maddy AI version diff · 1 comparison

What changed between versions

A2126 A2126A · 5 edits
MODERATE
The bill was amended to expand its scope by adding new sponsors and including ERISA plans (private employer health plans) alongside state entities. The text was also updated to change the definition of 'prescription drug' to align with state penal law and 'wholesale acquisition cost' to align with state tax law, while removing references to federal Medicaid definitions.
Scope change
The bill's scope expanded from applying only to state entities and health plans to also include 'Participating ERISA plans,' thereby extending the referenced rate requirements to private employer-sponsored health insurance plans.
SCOPE

Added 'Participating ERISA plan' and 'Participating ERISA plan' definitions, allowing private employer health plans to join the pilot program.

DEFINITION

Changed the definition of 'prescription drug' to match the Penal Law instead of the Education Law, and updated 'wholesale acquisition cost' to match the Tax Law instead of federal law.

Updated the 'State entity' definition to explicitly exclude Medicaid, clarifying that the program applies to state agencies but not the federal Medicaid program.

Removed a provision allowing non-prescription drugs to be added to the preferred drug list under specific public health law criteria.

REQUIREMENT

Reorganized the legislative findings section to include new points about rising state costs for public employee health care and the threat to public education funding.

Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
4
Key actions
2
Committee
2
Amendments
2
Jan 27, 2026
Lower · Passed
PRINT NUMBER 2126A
lower
Jan 27, 2026
Lower · Passed
AMEND AND RECOMMIT TO INSURANCE
lower
Jan 7, 2026
Committee
REFERRED TO INSURANCE
lower
Jan 15, 2025
Committee
REFERRED TO INSURANCE
lower
1 primary · 30 co-sponsors

Sponsors